The Latin America, Middle East and Africa Thyroid Ablation Devices Market should witness market growth of 17.0% CAGR during the forecast period (2022-2028).
Patients who are not surgical candidates benefit greatly from local and regional therapy using ablative technologies. RFA and MWA are the most significant thermal ablative systems, although other heat-ablative technologies like laser and HIFU also play a significant role in suppressing tumors. Microwave ablation has good technical performance andis less subject to the heat sink effect in circulatory organs like the liver and kidney and instead provides a uniform and bigger ablation zone.
With efforts to individualise treatment based on the nodule's aetiology and patient performance level, thyroid nodule treatment has considerably changed in recent years. The hazards and side effects of radioactive iodine and surgeryhave raised interest in alternative therapies including radiofrequency ablation (RFA). The main drivers of themarket for thyroid ablation devices are the rise in government funding for the treatment of Hashimoto's thyroiditis and the surge in demand for efficient therapies. In addition, important players who offer a variety of ablation products for the treatment of thyroid cancer, like Theraclion and Sonacare Medical, also contribute to the market's expansion.
In 2020, western Africa was one of the regions wherethe age-standardized incidence rate (ASIR) of thyroid cancerwas high. Age-standardized DALY rate for North Africa and the Middle East was 14.9 per 100,000 people in 2019, with an ASIR of 3.5 and a DALY rate that increased from 1990 to 2019.Health system outcomes in the Middle East andNorth Africa regionvary, according to a health system evaluation. Furthermore, individuals from this region are diagnosed to be more susceptible than others to thyroid cancer risk factors. Reporting the prevalence of thyroid cancer,therefore, assistshealth policymakers in allocating resources for disease control and prevention activities in the region. This supports the growth of the regional market.
The Brazil market dominated the LAMEA Thyroid Ablation Devices Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $5,006.3 Thousands by 2028. The Argentina market is experiencing a CAGR of 17.6% during (2022-2028). Additionally, The UAE market would showcase a CAGR of 16.7% during (2022-2028).
Based on End-use, the market is segmented into Hospitals, Ambulatory Surgical Centers (ASCs), Cancer Specialty Centers and Others. Based on Type, the market is segmented into Radiofrequency Ablation, Microwave Ablation and Others. Based on Application, the market is segmented into Thyroid Cancer and Thyroid Nodules. Based on Product, the market is segmented into Thermal-based Devices and Non-thermal-based Devices. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Boston Scientific Corporation, Integra LifeSciences Holdings Corporation, Johnson & Johnson, Theraclion SA, Olympus Corporation, Terumo Corporation, BVM Medical Limited, MedWaves, Inc., and STARmed Co. Ltd.
Patients who are not surgical candidates benefit greatly from local and regional therapy using ablative technologies. RFA and MWA are the most significant thermal ablative systems, although other heat-ablative technologies like laser and HIFU also play a significant role in suppressing tumors. Microwave ablation has good technical performance andis less subject to the heat sink effect in circulatory organs like the liver and kidney and instead provides a uniform and bigger ablation zone.
With efforts to individualise treatment based on the nodule's aetiology and patient performance level, thyroid nodule treatment has considerably changed in recent years. The hazards and side effects of radioactive iodine and surgeryhave raised interest in alternative therapies including radiofrequency ablation (RFA). The main drivers of themarket for thyroid ablation devices are the rise in government funding for the treatment of Hashimoto's thyroiditis and the surge in demand for efficient therapies. In addition, important players who offer a variety of ablation products for the treatment of thyroid cancer, like Theraclion and Sonacare Medical, also contribute to the market's expansion.
In 2020, western Africa was one of the regions wherethe age-standardized incidence rate (ASIR) of thyroid cancerwas high. Age-standardized DALY rate for North Africa and the Middle East was 14.9 per 100,000 people in 2019, with an ASIR of 3.5 and a DALY rate that increased from 1990 to 2019.Health system outcomes in the Middle East andNorth Africa regionvary, according to a health system evaluation. Furthermore, individuals from this region are diagnosed to be more susceptible than others to thyroid cancer risk factors. Reporting the prevalence of thyroid cancer,therefore, assistshealth policymakers in allocating resources for disease control and prevention activities in the region. This supports the growth of the regional market.
The Brazil market dominated the LAMEA Thyroid Ablation Devices Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $5,006.3 Thousands by 2028. The Argentina market is experiencing a CAGR of 17.6% during (2022-2028). Additionally, The UAE market would showcase a CAGR of 16.7% during (2022-2028).
Based on End-use, the market is segmented into Hospitals, Ambulatory Surgical Centers (ASCs), Cancer Specialty Centers and Others. Based on Type, the market is segmented into Radiofrequency Ablation, Microwave Ablation and Others. Based on Application, the market is segmented into Thyroid Cancer and Thyroid Nodules. Based on Product, the market is segmented into Thermal-based Devices and Non-thermal-based Devices. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Boston Scientific Corporation, Integra LifeSciences Holdings Corporation, Johnson & Johnson, Theraclion SA, Olympus Corporation, Terumo Corporation, BVM Medical Limited, MedWaves, Inc., and STARmed Co. Ltd.
Scope of the Study
By End-use
- Hospitals
- Ambulatory Surgical Centers (ASCs)
- Cancer Specialty Centers
- Others
By Type
- Radiofrequency Ablation
- Microwave Ablation
- Others
By Application
- Thyroid Cancer
- Thyroid Nodules
By Product
- Thermal-based Devices
- Non-thermal-based Devices
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Medtronic PLC
- Boston Scientific Corporation
- Integra LifeSciences Holdings Corporation
- Johnson & Johnson
- Theraclion SA
- Olympus Corporation
- Terumo Corporation
- BVM Medical Limited
- MedWaves, Inc.
- STARmed Co. Ltd.
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Thyroid Ablation Devices Market, by End-use
1.4.2 LAMEA Thyroid Ablation Devices Market, by Type
1.4.3 LAMEA Thyroid Ablation Devices Market, by Application
1.4.4 LAMEA Thyroid Ablation Devices Market, by Product
1.4.5 LAMEA Thyroid Ablation Devices Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. LAMEA Thyroid Ablation Devices Market by End-use
3.1 LAMEA Hospitals Market by Country
3.2 LAMEA Ambulatory Surgical Centers (ASCs) Market by Country
3.3 LAMEA Cancer Specialty Centers Market by Country
3.4 LAMEA Others Market by Country
Chapter 4. LAMEA Thyroid Ablation Devices Market by Type
4.1 LAMEA Radiofrequency Ablation Market by Country
4.2 LAMEA Microwave Ablation Market by Country
4.3 LAMEA Others Market by Country
Chapter 5. LAMEA Thyroid Ablation Devices Market by Application
5.1 LAMEA Thyroid Cancer Market by Country
5.2 LAMEA Thyroid Nodules Market by Country
Chapter 6. LAMEA Thyroid Ablation Devices Market by Product
6.1 LAMEA Thermal-based Devices Market by Country
6.2 LAMEA Non-thermal-based Devices Market by Country
Chapter 7. LAMEA Thyroid Ablation Devices Market by Country
7.1 Brazil Thyroid Ablation Devices Market
7.1.1 Brazil Thyroid Ablation Devices Market by End-use
7.1.2 Brazil Thyroid Ablation Devices Market by Type
7.1.3 Brazil Thyroid Ablation Devices Market by Application
7.1.4 Brazil Thyroid Ablation Devices Market by Product
7.2 Argentina Thyroid Ablation Devices Market
7.2.1 Argentina Thyroid Ablation Devices Market by End-use
7.2.2 Argentina Thyroid Ablation Devices Market by Type
7.2.3 Argentina Thyroid Ablation Devices Market by Application
7.2.4 Argentina Thyroid Ablation Devices Market by Product
7.3 UAE Thyroid Ablation Devices Market
7.3.1 UAE Thyroid Ablation Devices Market by End-use
7.3.2 UAE Thyroid Ablation Devices Market by Type
7.3.3 UAE Thyroid Ablation Devices Market by Application
7.3.4 UAE Thyroid Ablation Devices Market by Product
7.4 Saudi Arabia Thyroid Ablation Devices Market
7.4.1 Saudi Arabia Thyroid Ablation Devices Market by End-use
7.4.2 Saudi Arabia Thyroid Ablation Devices Market by Type
7.4.3 Saudi Arabia Thyroid Ablation Devices Market by Application
7.4.4 Saudi Arabia Thyroid Ablation Devices Market by Product
7.5 South Africa Thyroid Ablation Devices Market
7.5.1 South Africa Thyroid Ablation Devices Market by End-use
7.5.2 South Africa Thyroid Ablation Devices Market by Type
7.5.3 South Africa Thyroid Ablation Devices Market by Application
7.5.4 South Africa Thyroid Ablation Devices Market by Product
7.6 Nigeria Thyroid Ablation Devices Market
7.6.1 Nigeria Thyroid Ablation Devices Market by End-use
7.6.2 Nigeria Thyroid Ablation Devices Market by Type
7.6.3 Nigeria Thyroid Ablation Devices Market by Application
7.6.4 Nigeria Thyroid Ablation Devices Market by Product
7.7 Rest of LAMEA Thyroid Ablation Devices Market
7.7.1 Rest of LAMEA Thyroid Ablation Devices Market by End-use
7.7.2 Rest of LAMEA Thyroid Ablation Devices Market by Type
7.7.3 Rest of LAMEA Thyroid Ablation Devices Market by Application
7.7.4 Rest of LAMEA Thyroid Ablation Devices Market by Product
Chapter 8. Company Profiles
8.1 Medtronic PLC
8.1.1 Company overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 Recent strategies and developments:
8.1.5.1 Acquisition and Mergers:
8.1.6 SWOT Analysis
8.2 Boston Scientific Corporation
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.3 Integra LifeSciences Holdings Corporation
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.4 Johnson & Johnson
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental &Regional Analysis
8.4.4 Research & Development Expenses
8.5 Theraclion SA
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Research & Development Expenses
8.6 Olympus Corporation
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.7 Terumo Corporation
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Regional Analysis
8.8 BVM Medical Limited
8.8.1 Company Overview
8.9 MedWaves, Inc.
8.9.1 Company Overview
8.10. STARmed Co. Ltd.
8.10.1 Company Overview
Companies Mentioned
- Medtronic PLC
- Boston Scientific Corporation
- Integra LifeSciences Holdings Corporation
- Johnson & Johnson
- Theraclion SA
- Olympus Corporation
- Terumo Corporation
- BVM Medical Limited
- MedWaves, Inc.
- STARmed Co. Ltd.
Methodology
LOADING...
